Brief: Leap Therapeutics Reports Qtrly Loss Per Share Of $0.10

Cypherpunk Technologies

11/03/2022 12:07

March 11 (Reuters) - Leap Therapeutics Inc  LPTX.O :
    * LEAP THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2021
FINANCIAL RESULTS
    * QTRLY LOSS PER SHARE $0.10
    * QTRLY LICENSE REVENUE $375,000
    * Q4 EARNINGS PER SHARE VIEW $-0.11 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nPnbrXgZ7a 
Further company coverage:  LPTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))